ABT — Recent News Coverage
All news mentioning ABT in ESEN's AI-graded feed
News stories with ABT as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on ABT. See /coverage/ABT for the 30-day aggregate.
INSIDERMONKEY.COM
·
2026-08-10
NEUTRAL
BULLISH
CORR0.72
Abbott vs. Thermo Fisher: Is Diversification or the Life Sciences Recovery the Better Bet?
$ABT
$TMO
◈ ESEN AI
Abbott Laboratories (ABT) reported earnings that exceeded consensus and lifted full-year guidance, signaling momentum in diagnostics and medical devices. This represents a catalyst-free earnings beat—positive but proced…
INSIDERMONKEY.COM
·
2026-08-10
LOW
NEUTRAL
CORR0.42
Johnson & Johnson vs Abbott Laboratories: Which Healthcare Giant Offers the More Compelling Growth Story After Earnings?
$JNJ
$ABT
◈ ESEN AI
Johnson & Johnson reported Q2 2026 sales of $25.31 billion, a 7% year-over-year increase that marginally exceeded consensus expectations of $25.05 billion. While the beat demonstrates operational execution, the magnitud…
INSIDERMONKEY.COM
·
2026-08-07
NEUTRAL
BULLISH
CORR0.55
What Makes Abbott Laboratories (ABT) a Compelling Investment Opportunity with Reliable Growth
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) has been positioned as a compelling investment thesis by Matrix Asset Advisors in their Q2 2026 letter, highlighting the company's reliable growth profile and defensive characteristics within t…
FINANCE.YAHOO.COM
·
2026-08-04
NEUTRAL
BULLISH
CORR0.62
Abbott vs Danaher: Which Healthcare Stock Looks Better Positioned Following Earnings?
$ABT
$DHR
◈ ESEN AI
Abbott Laboratories (ABT) demonstrated operational momentum in Q2 2026 with earnings that exceeded consensus and a raised full-year guidance, signaling management confidence in sustained demand. The 13% reported sales g…
SEEKINGALPHA.COM
·
2026-07-29
LOW
NEUTRAL
CORR0.92
Matrix Asset Advisors Q2 2026 Capital Markets Commentary And Quarterly Report
$CMCSA
$PEP
$ABT
◈ ESEN AI
Matrix Asset Advisors' Large Cap Value Portfolio delivered mid-teens returns in Q2 2026, matching the performance trajectory of broad equity benchmarks. The portfolio's alignment with the S&P 500 suggests no significant…
INSIDERMONKEY.COM
·
2026-07-27
HIGH
BULLISH
CORR0.72
Abbott (ABT) Raised Its Profit Forecast. What’s Driving Its Growth?
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) has raised its full-year profit guidance following better-than-expected Q2 2026 earnings, signaling sustained momentum in its diagnostics and medical device segments. This upgrade represents ma…
FINANCE.YAHOO.COM
·
2026-07-27
NEUTRAL
BEARISH
CORR0.42
Abbott Laboratories (ABT) Fell as Guidance and Litigation Concerns Overshadowed Growth
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) experienced downward pressure following negative catalyst announcements centered on forward guidance revision and unresolved litigation exposure. While the fund commentary indicates this occurs…
ZACKS.COM
·
2026-07-27
NEUTRAL
BULLISH
CORR0.72
Zacks Investment Ideas feature highlights: General Motors, Abbott Laboratories and Johnson & Johnson
$GM
$ABT
$JNJ
◈ ESEN AI
GM, ABT, and JNJ have demonstrated earnings resilience during the current reporting cycle, each raising forward guidance and delivering results that exceeded consensus expectations. This pattern suggests management conf…
INSURANCEJOURNAL.COM
·
2026-07-20
NEUTRAL
NEUTRAL
CORR0.15
Abbott Investigates Two Separate Cyber Incidents, Says No Operations Affected
$ABT
◈ ESEN AI
Abbott Laboratories disclosed two concurrent cyber incidents involving unauthorized access to internal systems within its cancer diagnostics division. The company emphasized that operational continuity remains intact an…
FINANCE.YAHOO.COM
·
2026-07-19
LOW
BULLISH
CORR0.42
My 2 Favorite Dividend Kings to Buy Right Now
$ABBV
$ABT
$JNJ
◈ ESEN AI
This piece advocates for dividend-focused equities as portfolio stabilizers during elevated volatility. The analysis targets established dividend aristocrats—companies with multi-decade payout track records—positioning …
SEEKINGALPHA.COM
·
2026-07-17
NEUTRAL
BULLISH
CORR0.58
Abbott Laboratories Stock: Pick Up This Dividend King Deal Now (NYSE:ABT)
$ABT
$EXAS
◈ ESEN AI
Abbott Laboratories (ABT) is positioned to benefit from dual catalysts: sustained momentum in its diversified Medical Devices portfolio and integration synergies from the recently acquired Exact Sciences diagnostic plat…
RTTNEWS.COM
·
2026-07-17
HIGH
BULLISH
CORR0.72
Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch
$CDNA
$ATAI
$ABT
$LLY
◈ ESEN AI
CDNA's rally reflects regulatory clarity on molecular testing reimbursement, a meaningful inflection for diagnostic companies dependent on Medicare coverage decisions. The finalized Local Coverage Determination removes …
SEEKINGALPHA.COM
·
2026-07-16
NEUTRAL
NEUTRAL
CORR0.52
Abbott Laboratories (ABT) Q2 2026 Earnings Call Transcript
$ABT
◈ ESEN AI
Abbott Laboratories' Q2 2026 earnings call represents a routine disclosure event with limited immediate catalyst value. The transcript publication itself does not convey underlying earnings surprises, guidance changes, …
SEEKINGALPHA.COM
·
2026-07-16
HIGH
BULLISH
CORR0.72
Abbott Laboratories: Double Beat And Raise Surprises The Street (Rating Upgrade) (ABT)
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) delivered a double beat on Q2 earnings, exceeding both revenue and earnings-per-share expectations while simultaneously raising full-year 2026 guidance. This combination represents a rare catal…
RTTNEWS.COM
·
2026-07-16
HIGH
BULLISH
CORR0.72
Abbott Laboratories Stock Rises 12% Over Revenue Growth In Q2, Revised FY26 Outlook
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) delivered a material positive catalyst with 12% single-day appreciation following Q2 revenue growth and an upward revision to full-year 2026 guidance. This represents a significant re-rating in…
ECONOMICTIMES.INDIATIMES.COM
·
2026-07-16
HIGH
BULLISH
CORR0.72
Abbott Labs shares jump 12% as Q2 sales rise, profit outlook raised
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) delivered a significant earnings beat in Q2, prompting a 12% intraday rally. The strength stems from robust top-line performance in medical devices and diagnostics, two high-margin segments tha…
RTTNEWS.COM
·
2026-07-16
HIGH
BULLISH
CORR0.72
Abbott Q2 Profit Plunges, Lifts FY26 Adj. EPS View, Backs Sales Forecast; Stock Up 11%
$ABT
◈ ESEN AI
Abbott Laboratories reported a significant quarterly profit decline but counterintuitively raised its fiscal 2026 adjusted EPS guidance, signaling management confidence in forward earnings trajectory despite near-term h…
SEEKINGALPHA.COM
·
2026-07-16
HIGH
BULLISH
CORR0.72
Abbott rises as guidance hike tops expectations (ABT:NYSE)
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) delivered a market-moving catalyst by reporting Q2 2026 results that exceeded consensus expectations and subsequently raising full-year guidance above analyst estimates. This represents a rare …
SEEKINGALPHA.COM
·
2026-07-15
NEUTRAL
BULLISH
CORR0.58
Abbott Laboratories Q2 preview: Analysts see healthy growth backed by Exact Sciences acquisition
$ABT
$EXAS
◈ ESEN AI
Abbott Laboratories (ABT) is positioned to deliver solid second-quarter results driven by organic growth momentum and the strategic integration of its Exact Sciences acquisition. The pre-earnings preview highlights anal…
INSIDERMONKEY.COM
·
2026-07-13
NEUTRAL
BULLISH
CORR0.58
Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) has received an Outperform initiation from Baird, signaling analyst confidence in the diversified healthcare and diagnostics player. This rating upgrade reflects positive conviction on the comp…
FINANCE.YAHOO.COM
·
2026-07-13
NEUTRAL
BULLISH
CORR0.58
Baird Initiates Coverage on Abbott Laboratories (ABT) Stock with Outperform Rating
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) received an initiating coverage call from Baird with an Outperform rating and $121.00 price target, signaling analyst confidence in the diversified healthcare conglomerate's forward trajectory.…
SEEKINGALPHA.COM
·
2026-07-12
NEUTRAL
NEUTRAL
CORR0.52
Wall Street Brunch: Will AI Steal Earnings Spotlight From Banks? (undefined:TSM)
$TSM
$ASML
$JNJ
$ABT
◈ ESEN AI
The article frames an emerging narrative tension between AI semiconductor demand and traditional banking earnings visibility. TSM and ASML are positioned as demand proxies for the artificial intelligence cycle, suggesti…
INSIDERMONKEY.COM
·
2026-07-10
NEUTRAL
BULLISH
CORR0.72
12 Best Monopoly Stocks to Buy According to Hedge Funds
$ABT
◈ ESEN AI
This article identifies monopoly-positioned stocks favored by hedge fund allocators, reflecting institutional conviction in competitive moat characteristics. The mention of ABT alongside broader hedge fund selection sug…
FINANCE.YAHOO.COM
·
2026-07-06
LOW
BULLISH
CORR0.42
3 Stocks to Buy and Hold: The Long-Term Play for Your Portfolio
$ABT
$JNJ
◈ ESEN AI
This article promotes a buy-and-hold thesis for healthcare equities, emphasizing defensive characteristics and income generation. The selection criteria—stability, dividend yield, and consistent growth—reflect positioni…
FINANCE.YAHOO.COM
·
2026-07-04
LOW
NEUTRAL
CORR0.35
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?
$ABBV
$ABT
$MRK
◈ ESEN AI
This comparative analysis examines two pharmaceutical sector ETFs—VanEck PPH and Invesco PJP—highlighting structural differences in their approach to capturing pharma opportunity. The article focuses on portfolio constr…
FINANCE.YAHOO.COM
·
2026-07-04
LOW
NEUTRAL
CORR0.42
State Street Health Care ETF Tops Invesco Pharma on Cost and Size
$ABBV
$ABT
$JNJ
◈ ESEN AI
This article presents a comparative analysis of two health care-focused exchange-traded funds with distinct structural and strategic orientations. The State Street offering emphasizes cost efficiency and broader sector …
SEEKINGALPHA.COM
·
2026-07-03
NEUTRAL
BULLISH
CORR0.58
Abbott Laboratories Q2 Earnings Preview: A Contrarian Buy Opportunity Worth Considering
$ABT
$EXAS
◈ ESEN AI
Abbott Laboratories (ABT) has received a buy rating upgrade ahead of second-quarter 2026 earnings, with the catalyst centered on the company's acquisition of Exact Sciences. This strategic combination positions ABT to c…
THESMARTINVESTOR.COM.SG
·
2026-07-01
LOW
NEUTRAL
CORR0.45
How to Get Paid Every Month with Just 3 US Healthcare Stocks
$ABT
◈ ESEN AI
This article presents a tactical income-generation strategy focused on healthcare dividend payers, specifically highlighting how staggered dividend payment calendars across three healthcare stocks can create monthly cas…
INSURANCEJOURNAL.COM
·
2026-06-30
HIGH
BULLISH
CORR0.72
DOJ Closes Criminal Probe Into Abbott Over Baby Formula Plant, WSJ Reports
$ABT
◈ ESEN AI
The Department of Justice's closure of its criminal investigation into Abbott Laboratories represents a significant de-risking event for the company and removes a major overhang that had weighed on investor sentiment si…
ECONOMICTIMES.INDIATIMES.COM
·
2026-06-29
NEUTRAL
BULLISH
CORR0.42
US DOJ closes criminal probe into Abbott over baby formula plant: Report
$ABT
◈ ESEN AI
The Department of Justice's decision to close its criminal investigation into Abbott Laboratories (ABT) regarding the 2022 baby formula plant incident represents a material de-risking event for the company. While the cl…
FINANCE.YAHOO.COM
·
2026-06-28
NEUTRAL
BULLISH
CORR0.42
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000
$ABT
◈ ESEN AI
Abbott Labs (ABT) is positioned as a defensive equity play in volatile market conditions, with the article emphasizing its dividend growth and valuation near $1,000 per share. The thesis centers on downside resilience a…
INSIDERMONKEY.COM
·
2026-06-25
NEUTRAL
BULLISH
CORR0.58
How Does Wall Street View Abbott Laboratories (ABT)’s Outlook?
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) received a reiterated "Buy" rating from Citi on June 17, 2026, signaling analyst confidence in the diversified healthcare conglomerate's near-term trajectory. The rating renewal, while not shoc…
FINANCE.YAHOO.COM
·
2026-06-22
LOW
BULLISH
CORR0.42
5 Dividend Stocks to Buy and Hold Forever
$ABBV
$ABT
$MCD
◈ ESEN AI
This is a thematic buy-and-hold editorial rather than event-driven news. The piece promotes dividend reinvestment as a wealth-building mechanism, focusing on ABBV, ABT, and MCD as exemplars of stable income generation. …
FINANCE.YAHOO.COM
·
2026-06-20
NEUTRAL
NEUTRAL
CORR0.42
Should You Buy Abbott Labs Stock Hand Over Fist Before July 16?
$ABT
◈ ESEN AI
Abbott Labs (ABT) faces a typical pre-earnings evaluation window ahead of its July 16 results announcement. The headline's rhetorical framing—"hand over fist"—suggests urgency, but the underlying thesis emphasizes that …
INSIDERMONKEY.COM
·
2026-06-14
LOW
BULLISH
CORR0.52
Abbott Laboratories (ABT): One of the Best Bargain Stocks to Buy in June
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) is being positioned as a bargain opportunity in June, suggesting the stock may be trading below intrinsic value or consensus targets. This type of screening typically reflects valuations attrac…
SEEKINGALPHA.COM
·
2026-06-12
NEUTRAL
BULLISH
CORR0.62
Abbott Laboratories Remains Structurally Undervalued (NYSE:ABT)
$ABT
◈ ESEN AI
Abbott Laboratories (ABT) is characterized as structurally undervalued relative to its sector peers, driven primarily by strategic acquisitions and exposure to growing global diagnostics demand. The analysis centers on …
EXPLORE OTHER FILTERS